Diphenyl Pyraline
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Diphenylpyraline (HCl) is a H1 receptor antagonist with anticholinergic and sedative effects. Diphenylpyraline (HCl) is used as antihistaminic agent in the treatment of allergic symptoms. Diphenylpyraline (HCl) is administered orally.
Indications
Diphenylpyraline is primarily indicated in conditions like Cold, Cough, Pruritus, Rhinitis, Skin diseases, and can also be given in adjunctive therapy as an alternative drug of choice in Parkinsonism.
Contraindications
Diphenylpyraline is contraindicated in conditions like Heart disease,
Jaundice, Urinary tract infection, Glaucoma.
Side Effects
The severe or irreversible adverse effects of Diphenylpyraline, which give rise to further complications include Hypotension, Paresthesia, Anemia. Diphenylpyraline produces potentially life-threatening effects which include Convulsions. which are responsible for the discontinuation of Diphenyl Pyralinetherapy. The signs and symptoms that are produced after the acute overdosage of Diphenylpyraline include Extrapyramidal effects, CNS effects. The symptomatic adverse reactions produced by Diphenylpyraline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Myalgia, Insomnia, Rashes, Confusion, Sedation, Sweating, Diplopia, Sensitivity.
Warnings
Diphenylpyraline should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not administer S/C because irritation or lesion may occur.
High Risk Groups
Drug should not be given to Paediatrics, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
No adult dosage information is recorded for this medicine yet.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Diphenyl Pyraline was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No active brands are currently recorded for this generic.
1 record is present but flagged "Unverified / Legacy" and excluded.